TRUOLMI H (Class 5)
#5045637
Application Number:5045637
Status:
Unknown
Class:5
Applicant: BINITA SRIVASTAVA
Filing Date:Thu, 15 Jul 2021
In Progress
Is this your trademark application?
"TRUOLMI H" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | TRUOLMI H |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5045637 |
| Nature/Scope of business | Oral Tablets for human consumption to treat uncontrolled high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). Hydrochlorothiazide is for management of edema associated with CHF. |
| Publication | In Journal No. 2148 |
| Status | Unknown |
| Applicant: | BINITA SRIVASTAVA |
| Applicant Address | N8/247, H-6 Newada Sunderpur, Proprietor |
| Jurisdiction | DELHI |
| Agent | DILEEP KUMAR SRIVASTAVA |
| Agent Address | FLAT NO.13 PREM APARTMENT,PREM NAGAR, SAPRU MARG, HAZRATGANJ, LUCKNOW 226001 |
Frequently Asked Questions
Who is the owner of trademark TRUOLMI H? ▾
The trademark application number 5045637 is owned by BINITA SRIVASTAVA.
Which class does trademark TRUOLMI H belong to? ▾
Trademark application number 5045637 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5045637? ▾
The trademark agent associated with application number 5045637 is DILEEP KUMAR SRIVASTAVA.
Was trademark TRUOLMI H published in the journal? ▾
Yes, trademark application number 5045637 was published in Journal No. 2148.
What is trademark TRUOLMI H? ▾
Trademark application number 5045637 relates to "Oral Tablets for human consumption to treat uncontrolled high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Olmesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). Hydrochlorothiazide is for management of edema associated with CHF.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified